Harvard and Guangzhou Institute of Respiratory Health Form $115 Million COVID-19 Collaboration

哈佛大学:携手钟南山与广州呼吸健康研究院
Published on: February 26, 2020
Author: Amy Liu

Harvard University and the Guangzhou Institute of Respiratory Health will collaborate to fight COVID-19 over the next five years in an effort funded by $115 million. The funding was provided by China Evergrande Group. The researchers plan to elucidate the basic biology of the virus, which will be used to design therapeutics/vaccines, develop accurate rapid diagnostics and identify biomarkers. The effort will include Harvard Medical School researchers, led by Dean George Q. Daley, along with Dr. Nanshan Zhong of the Guangzhou Institute, a pulmonologist and epidemiologist who heads China’s 2019n-CoV Expert Taskforce. Dr. Zhong discovered the SARS vaccine in 2003.

Source: China Biotoday

Biotechnology Life Science